title: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group.
abstract: Diabetic nephropathy is a glomerular disease due to uncontrolled diabetes and genetic factors. It can be caused by glomerular hypertension produced by capillary vasodilation, due to diabetes, against constitutional glomerular resistance. As angiotensin II increases glomerular pressure, we studied the relationship between genetic polymorphisms in the renin-angiotensin system-angiotensin I converting enzyme (ACE), angiotensinogen (AGT), and angiotensin II, subtype 1, receptor-and the renal involvement of insulin-dependent diabetic subjects with proliferative retinopathy: those exposed to the risk of nephropathy due to diabetes. Of 494 subjects recruited in 17 centers in France and Belgium (GENEDIAB Study), 157 (32%) had no nephropathy, 104 (21%) incipient (microalbuminuria), 126 (25 %) established (proteinuria), and 107 (22%) advanced (plasma creatinine > or = 150 micromol/liter or renal replacement therapy) nephropathy. The severity of renal involvement was associated with ACE insertion/deletion (I/D) polymorphism: chi2 for trend 5.135, P = 0.023; adjusted odds ratio attributable to the D allele 1.889 (95% CI 1.209-2.952, P = 0.0052). Renal involvement was not directly linked to other polymorphisms. However, ACE I-D and AGT M235T polymorphisms interacted significantly (P = 0.0166): in subjects with ACE ID and DD genotypes, renal involvement increased from the AGT MM to TT genotypes. Thus, genetic determinants that affect renal angiotensin II and kinin productions are risk factors for the progression of glomerular disease in uncontrolled insulin-dependent diabetic patients.
authors.affiliation: University Hospital, Angers, France.
authors.forename: M
authors.initials: M
authors.lastname: Marre
authors.forename: X
authors.initials: X
authors.lastname: Jeunemaitre
authors.forename: Y
authors.initials: Y
authors.lastname: Gallois
authors.forename: M
authors.initials: M
authors.lastname: Rodier
authors.forename: G
authors.initials: G
authors.lastname: Chatellier
authors.forename: C
authors.initials: C
authors.lastname: Sert
authors.forename: L
authors.initials: L
authors.lastname: Dusselier
authors.forename: Z
authors.initials: Z
authors.lastname: Kahal
authors.forename: L
authors.initials: L
authors.lastname: Chaillous
authors.forename: S
authors.initials: S
authors.lastname: Halimi
authors.forename: A
authors.initials: A
authors.lastname: Muller
authors.forename: H
authors.initials: H
authors.lastname: Sackmann
authors.forename: B
authors.initials: B
authors.lastname: Bauduceau
authors.forename: F
authors.initials: F
authors.lastname: Bled
authors.forename: P
authors.initials: P
authors.lastname: Passa
authors.forename: F
authors.initials: F
authors.lastname: Alhenc-Gelas
mesh_terms: D000328:Adult; D000368:Aged; D000808:Angiotensinogen / Q000235:genetics; D003430:Cross-Sectional Studies; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000209:etiology*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D007703:Peptidyl-Dipeptidase A / Q000235:genetics; D011110:Polymorphism, Genetic; D012084:Renin-Angiotensin System / Q000235:genetics*
chemical_list: D000808:Angiotensinogen; D007703:Peptidyl-Dipeptidase A